C160157Level 4

CPTAC Responses

**Semantic type:** Intellectual Product

GET/api/v1/systems/nci_thesaurus/nodes/C160157

Official DownloadCC BY 4.0Source

Hierarchy Explorer

Hierarchy ExplorerChevron to expand - click title to open

C156850New Tumor Event After Initial Treatment Present

C157411Current Oral Contraceptive User

C157416Performance Status Scale Timing Not Evaluated

C158798Not Applicable - Never Quit

C158832Melanoma Related Only Event Occurred after Initial Treatment

C158833Non-Melanoma Related Only Event Occurred after Initial Treatment

C158875Specify Site of Metastasis

C159229Cytogenetic Risk Group-CALGB Criteria for AML

C159324Left Lymph Node Dissection not Done

C159325Right Lymph Node Dissection not Done

C159545Bladder, NOS

C159568Stomach, NOS

C159586Preoperative IV Sedation was Not Administered

C159587Preoperative IV Sedation was Administered

C159589Preoperative IV Opiates were Administered

C159590Other Preoperative IV Medications were Administered

C159592Preoperative IV Antiemetics were Administered

C159593Preoperative IV Antacids were Administered

C159595Preoperative IV Antacids were not Administered

C159596Preoperative IV Antiemetics were not Administered

C159597Other Preoperative IV Medications were not Administered

C159598Preoperative IV Opiates were not Administered

C159603Local Anesthesia Agents were not Administered

C159604Local Anesthesia Agents were Administered

C159605Regional Anesthesia was Administered

C159606Regional Anesthesia was not Administered

C159607IV Anesthesia was Administered

C159608IV Anesthesia was not Administered

C159613Other Histologic Type

C159772Menopause Status not Evaluated

C159815Performance Status Scale Timing Unknown

C159816Performance Status Scale Timing Not Applicable

C159818HPV-Other Type

C160156Unknown Site of New Tumor Event

C160162Therapeutic Ionizing Radiation to Head History Present

C160163Therapeutic Ionizing Radiation to Head History Absent

C160164Therapeutic Ionizing Radiation to Head History Unknown

C160165First Degree Family History Cancer Positive

C160166First Degree Family History Cancer Negative

C160167First Degree Family History Cancer Unknown

C160168First Degree Family History of Primary Brain Tumor Positive

C160169First Degree Family History of Primary Brain Tumor Negative

C160170First Degree Family History of Primary Brain Tumor Unknown

C160173First Presenting Symptom Related to Disease Unknown

C160178Non-Neoplastic Finding Absent

C160179History of Medical Treatment Present

C160180History of Medical Treatment Absent

C160181History of Medical Treatment Unknown

C160182Cancer History Present

C160185Cancer History Absent

C160187Cancer History Unknown

C160191History of Other Medical Treatment

C160193Documentation Present

C160194Documentation Absent

C160196Documentation Unknown

C160198Unknown Tumor Zone

C160199Tumor Laterality Right

C160200Tumor Laterality Left

C160201Tumor Laterality Bilateral

C160205Family History of Stomach Cancer Present

C160206Family History of Stomach Cancer Absent

C160208Bilateral Thyroid Glands

C160209Thyroid, NOS

C160210First Degree Family History Thyroid Cancer Negative

C160211First Degree Family History Thyroid Cancer Positive

C160212First Degree Family History Thyroid Cancer Unknown

C160213Radiation History Unknown

C160214Radiation History Positive

C160215Radiation History Negative

C160216Adjuvant I-131 Therapy Positive

C160217Adjuvant I-131 Therapy Negative

C160218Adjuvant I-131 Therapy Unknown

C160228First Course Treatment Completion Measure of Success of Outcome Not Applicable

C160234Few Tumor Infiltrating Lymphocytes

C160235Many Tumor Infiltrating Lymphocytes

C160236Moderate Tumor Infiltrating Lymphocytes

C160237Unknown Tumor Infiltrating Lymphocytes

C160243Unknown Eye Color

C160244Other Eye Color

C160247Patient was Postmenopausal with no Prior Oophorectomy

C160248Patient was not Postmenopausal with no Prior Oophorectomy

C160249Currently Using Menopausal Hormone Therapy

C160250Formerly Used Menopausal Hormone Therapy

C160251Never Used Menopausal Hormone Therapy

C160252Unknown Use of Menopausal Hormone Therapy

C160253Another Form of Birth Control was Used

C160254Another Form of Birth Control was not Used

C160255Unknown if Another form of Birth Control was Used

C160259Current User Tamoxifen

C160260Former User Tamoxifen

C160261Never Used Tamoxifen

C160262Unknown Tamoxifen Use

C160263Unknown Number of Full Term Pregnancies

C160264Adjuvant Post-operative Radiation Therapy Was Administered

C160265Adjuvant Post-operative Radiation Therapy Was Not Administered

C160266Adjuvant Post-operative Radiation Therapy Administration Unknown

C160267Adjuvant Post-operative Pharmaceutical Therapy Was Administered

C160268Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered

C160269Adjuvant Post-operative Pharmaceutical Therapy Administration Unknown

C160270Adjuvant Post-operative Immunological Therapy Was Administered

C160271Adjuvant Post-operative Immunological Therapy Was Not Administered

C160272Adjuvant Post-operative Immunological Therapy Administration Unknown

C160274Hypertension Present

C160275Hypertension Absent

C160276Hypertension Unknown

C160277Physician Diagnosed Diabetes Present

C160278Physician Diagnosed Diabetes Unknown

C160279Physician Diagnosed Diabetes Absent

C160280History of Colorectal Cancer Positive

C160281History of Colorectal Cancer Negative

C160282History of Colorectal Cancer Unknown

C160284Follow-Up Form Outcome Measure of Success Not Applicable

C160285Performance Status Scale Timing Other

C160286New Tumor Event After Initial Treatment Absent

C160287New Tumor Event After Initial Treatment Unknown

C160288Testing Was Not Performed

C160289Testing Was Performed

C160290Not Known if Testing Was Performed

C160299Additional Surgery for New Tumor Event Present

C160300Additional Surgery for New Tumor Event Absent

C160302Additional Surgery for New Tumor Event Unknown

C160307Unknown Procedure Type for New Tumor Event

C160327Bone Marrow Transplantation Performed

C160329Bone Marrow Transplantation Not Performed

C160331Bone Marrow Transplantation Status Unknown

C160336Chemotherapy Received

C160337Chemotherapy Not Received

C160338Chemotherapy Status Unknown

C160339Immunotherapy Received

C160340Immunotherapy Not Received

C160341Immunotherapy Status Unknown

C160342Pharmacotherapy Received

C160343Pharmacotherapy Not Received

C160344Pharmacotherapy Status Unknown

C160345Radiation Therapy Was Received

C160346Radiation Therapy Not Received

C160347Radiation Therapy Status Unknown

C160374Adjuvant Post-operative Chemotherapy Was Administered

C160375Adjuvant Post-operative Chemotherapy Was Not Administered

C160376Adjuvant Post-operative Chemotherapy Administration Unknown

C160377Adjuvant Post-operative Hormone Therapy Was Administered

C160378Adjuvant Post-operative Hormone Therapy Was Not Administered

C160379Adjuvant Post-operative Hormone Therapy Administration Unknown

C160388Adjuvant Post-operative Targeted Molecular Therapy Was Administered

C160389Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered

C160390Adjuvant Post-operative Targeted Molecular Therapy Administration Unknown

C160393First Course Treatment Completion Measure of Success of Outcome Unknown

C160402Follow-Up Form Completion Outcome Measure of Success Unknown

C160403Follow-Up Form Completion Outcome Measure of Success Not Applicable

C160424Non-Regional Lymph Node New Tumor Event

C160444Additional Surgery for New Loco-Regional Tumor Event Was Performed

C160445Additional Surgery for New Loco-Regional Tumor Event Was Not Performed

C160446Additional Surgery for New Loco-Regional Tumor Event Unknown

C160447Additional Surgery for New Metastatic Tumor Event Unknown

C160449Additional Surgery for New Metastatic Tumor Event Was Not Performed

C160450Additional Surgery for New Metastatic Tumor Event Was Performed

C160467Use of Smokeless Tobacco at Time of Diagnosis Positive

C160469Use of Smokeless Tobacco at Time of Diagnosis Negative

C160470Use of Smokeless Tobacco at Time of Diagnosis Unknown

C160471Regular Smokeless Tobacco Use for Six Weeks or More Positive

C160472Regular Smokeless Tobacco Use for Six Weeks or More Negative

C160473Regular Smokeless Tobacco Use for Six Weeks or More Unknown

C160474Average Daily Use Smokeless Tobacco after Use for Six Weeks Unknown

C160601Evidence of Disease Present after Completion of Therapy

C160602Evidence of Disease Absent after Completion of Therapy

C160604Evidence of Disease Unknown after Completion of Therapy

C160609Surgical Procedure was Curative Therapy

C160610Non-Concurrent Chemotherapy was Curative Therapy

C160611Concurrent Chemotherapy was Curative Therapy

C160612Radiation Therapy was Curative Therapy

C160620Tumor Reoccurrence Present After Initial Treatment

C160622Tumor Reoccurrence Absent After Initial Treatment

C160623Tumor Reoccurrence Unknown After Initial Treatment

C160634Radiation Was Administered as an Additional Treatment for a New Tumor Event

C160635Radiation Was Not Administered as an Additional Treatment for a New Tumor Event

C160636Unknown if Radiation Was Administered as an Additional Treatment for a New Tumor Event

C160637Chemotherapy Was Administered as an Additional Treatment for a New Tumor Event

C160638Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event

C160639Unknown if Chemotherapy Was Administered as an Additional Treatment for a New Tumor Event

C160640Immunotherapy Was Administered as an Additional Treatment for a New Tumor Event

C160641Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event

C160642Unknown if Immunotherapy Was Administered as an Additional Treatment for a New Tumor Event

C160643Hormone Therapy Was Administered as an Additional Treatment for a New Tumor Event

C160644Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event

C160645Unknown if Hormone Therapy Was Administered as an Additional Treatment for a New Tumor Event

C160646Targeted Molecular Therapy Was Administered as an Additional Treatment for a New Tumor Event

C160647Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event

C160648Unknown if Targeted Molecular Therapy Was Administered as an Additional Treatment for a New Tumor Event

C160667Melanoma and Non-Melanoma Related Event Occurred after Initial Treatment

C160671Current Hormonal Contraceptive User

C160672Former Hormonal Contraceptive User

C160673Never Used Hormonal Contraceptives

C160674Unknown Use of Hormonal Contraceptives

C160675Human Immunodeficiency Virus Unknown

C160676Specify Other Histologic Type

C160680Family History of Stomach Cancer Unknown

C160681New Disease is Multifocal

C160682New Disease is not Multifocal

C160683Unknown if New Disease is Multifocal

C160688Additional Pharmacotherapy for New Tumor Event Absent

C160689Additional Pharmacotherapy for New Tumor Event Received

C160690Additional Pharmacotherapy for New Tumor Event Unknown

C160697Indeterminate Ulceration

C160698Multiple Known Primary Tumors Present at Initial Melanoma Diagnosis

C160699Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis

C160700Multiple Known Primary Tumors Unknown at Initial Melanoma Diagnosis

C160701Unknown Clark Level

C160702Tumor Necrosis Not Identified

C160703Tumor Necrosis Present

C160705Margin Status Cannot be Assessed

C160707Ulceration is Present

C160708Ulceration is Absent

C160709No Pathologic Findings Identified

C160710Other Pathologic Findings

C160713GIST Grade Cannot be Assessed

C160721Lymphatic Invasion Absent

C160730FNCLCC Sarcoma Grade GX Grade cannot be assessed

C160735Paraneoplastic Syndrome is Not Present

C160736Paraneoplastic Syndrome Status is Unknown

C160738Tumor Progression Present After Initial Treatment

C160739Tumor Progression Absent After Initial Treatment

C160740Tumor Progression Unknown After Initial Treatment

C160741Subsequent Known Primary Melanoma(s) Found During the Follow-Up

C160742Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up

C160743Unknown if Subsequent Known Primary Melanoma(s) Found During the Follow-Up

C160745Additional Surgery for New Metastatic Tumor Event Not Evaluated

C160754Routine Cytogenetics Were Completed

C160755Routine Cytogenetics Were not Completed

C160756Unknown if Routine Cytogenetics were Completed

C160761Other Cytogenetic Analysis Abnormality Type

C160762Specify if Other Cytogenetic Analysis Abnormality Type

C160763Other Molecular Analysis

C160764Unknown Molecular Analysis

C160765Specify Other Molecular Analysis

C160767Molecular Abnormalities Detected

C160768Molecular Abnormalities Not Detected

C160769Molecular Abnormalities Unknown

C160790Other Histologic Grade

C160791Specify Other Histologic Grade

C160792Myometrial Invasion Not Identified

C160821Peritoneal Fluid is Negative for Malignancy

C160822Atypical Peritoneal Fluid

C160823Peritoneal Fluid Positive for Malignancy

C160825Peritoneal Fluid Not Examined

C160839Interferon Gamma Treatment was Administered Prior to Specimen Resection

C160840Interferon Gamma Treatment was not Administered Prior to Specimen Resection

C160841Unknown if Interferon Gamma Treatment was Administered Prior to Specimen Resection

C160842Interferon Gamma Treatment was Administered 90 Days Prior to Specimen Resection

C160843Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection

C160844Interferon Gamma Treatment Administration 90 Days Prior to Specimen Resection Unknown

C160846Sarcomatoid Features Absent

C162598Additional Surgery for new Loco-Regional Tumor Event Not Evaluated

C162603Additional Surgery for New Tumor Event Not Evaluated

C162604Paraneoplastic Syndrome is Present

C162605Lymphatic Invasion is Present

C162606Tumor Cell Necrosis is Present

C162607Tumor Infiltrating Lymphocyte is Present

C162614Tumor Laterality Midline

C162615Tumor Laterality Unknown

C162708No 30 Day Prior Medications

C165749Tumor Location Unknown

Cross-system equivalences0

No cross-system equivalences mapped for this node.

Report a data issue